Previous close | 87.24 |
Open | 87.35 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 800 |
Day's range | 85.98 - 87.35 |
52-week range | 60.57 - 96.12 |
Volume | |
Avg. volume | 4,026,537 |
Market cap | 52.037B |
Beta (5Y monthly) | 1.07 |
PE ratio (TTM) | 37.59 |
EPS (TTM) | 2.30 |
Earnings date | 25 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 94.28 |
Community Health's (CYH) first-quarter results are likely to reflect declining beds in services and adjusted admissions.
The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.